Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Dickson

Showing results (41-50 of 93) with videos related to

Pageof 10
Sort By:
Molecular Therapy. Methods & Clinical Development|August 14, 2018
Genetically Corrected iPSC-Derived Neural Stem Cell Grafts Deliver Enzyme Replacement to Affect CNS Disease in Sanfilippo B MiceDon Clarke, Yewande Pearse, Shih-Hsin Kan, et al.
Neurology. Genetics|December 16, 2022
Whole-Genome and Long-Read Sequencing Identify a Novel Mechanism in <i>RFC1</i> Resulting in CANVAS SyndromeKatherine Abell King, Daniel J Wegner, Robert C Bucelli, et al.
Scientific Reports|December 3, 2016
Elevated cerebral spinal fluid biomarkers in children with mucopolysaccharidosis I-HGerald V Raymond, Marzia Pasquali, Lynda E Polgreen, et al.
The Neuroradiology Journal|July 14, 2017
Quantitative diffusion tensor imaging analysis does not distinguish pediatric canines with mucopolysaccharidosis I from control caninesDana M Middleton, Jonathan Y Li, Steven D Chen, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 9, 2011
Arterial pathology in canine mucopolysaccharidosis-I and response to therapyJeremiah A Lyons, Patricia I Dickson, Jonathan S Wall, et al.
Molecular Genetics and Metabolism|July 20, 2015
Intrathecal 2-hydroxypropyl-beta-cyclodextrin in a single patient with Niemann-Pick C1Timothy J Maarup, Agnes H Chen, Forbes D Porter, et al.
Plos One|March 18, 2016
Immune-Mediated Inflammation May Contribute to the Pathogenesis of Cardiovascular Disease in Mucopolysaccharidosis Type IOmar Khalid, Moin U Vera, Philip L Gordts, et al.
The Neuroradiology Journal|June 21, 2017
Diffusion tensor imaging tensor shape analysis for assessment of regional white matter differencesDana M Middleton, Jonathan Y Li, Hui J Lee, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 23, 2020
Comparison of dermatan sulfate and heparan sulfate concentrations in serum, cerebrospinal fluid and urine in patients with mucopolysaccharidosis type I receiving intravenous and intrathecal enzyme replacement therapyHaoyue Zhang, Patricia I Dickson, Ashlee R Stiles, et al.
Molecular Genetics and Metabolism|March 10, 2012
Specific antibody titer alters the effectiveness of intrathecal enzyme replacement therapy in canine mucopolysaccharidosis IPatricia I Dickson, N Matthew Ellinwood, Jillian R Brown, et al.
Pageof 10

Showing results (41-50 of 93) with videos related to

Sort By:
Pageof 10
Molecular Therapy. Methods & Clinical Development|August 14, 2018
Genetically Corrected iPSC-Derived Neural Stem Cell Grafts Deliver Enzyme Replacement to Affect CNS Disease in Sanfilippo B MiceDon Clarke, Yewande Pearse, Shih-Hsin Kan, et al.
Neurology. Genetics|December 16, 2022
Whole-Genome and Long-Read Sequencing Identify a Novel Mechanism in <i>RFC1</i> Resulting in CANVAS SyndromeKatherine Abell King, Daniel J Wegner, Robert C Bucelli, et al.
Scientific Reports|December 3, 2016
Elevated cerebral spinal fluid biomarkers in children with mucopolysaccharidosis I-HGerald V Raymond, Marzia Pasquali, Lynda E Polgreen, et al.
The Neuroradiology Journal|July 14, 2017
Quantitative diffusion tensor imaging analysis does not distinguish pediatric canines with mucopolysaccharidosis I from control caninesDana M Middleton, Jonathan Y Li, Steven D Chen, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 9, 2011
Arterial pathology in canine mucopolysaccharidosis-I and response to therapyJeremiah A Lyons, Patricia I Dickson, Jonathan S Wall, et al.
Molecular Genetics and Metabolism|July 20, 2015
Intrathecal 2-hydroxypropyl-beta-cyclodextrin in a single patient with Niemann-Pick C1Timothy J Maarup, Agnes H Chen, Forbes D Porter, et al.
Plos One|March 18, 2016
Immune-Mediated Inflammation May Contribute to the Pathogenesis of Cardiovascular Disease in Mucopolysaccharidosis Type IOmar Khalid, Moin U Vera, Philip L Gordts, et al.
The Neuroradiology Journal|June 21, 2017
Diffusion tensor imaging tensor shape analysis for assessment of regional white matter differencesDana M Middleton, Jonathan Y Li, Hui J Lee, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 23, 2020
Comparison of dermatan sulfate and heparan sulfate concentrations in serum, cerebrospinal fluid and urine in patients with mucopolysaccharidosis type I receiving intravenous and intrathecal enzyme replacement therapyHaoyue Zhang, Patricia I Dickson, Ashlee R Stiles, et al.
Molecular Genetics and Metabolism|March 10, 2012
Specific antibody titer alters the effectiveness of intrathecal enzyme replacement therapy in canine mucopolysaccharidosis IPatricia I Dickson, N Matthew Ellinwood, Jillian R Brown, et al.
Pageof 10